TipRanks
Advertisement
Advertisement
Jazz Pharmaceuticals Completes $1.25 Billion Notes Offering
PremiumCompany AnnouncementsJazz Pharmaceuticals Completes $1.25 Billion Notes Offering
23d ago
Jazz reports second interim overall survival results for HERIZON-GEA-01 trial
Premium
The Fly
Jazz reports second interim overall survival results for HERIZON-GEA-01 trial
23d ago
Jazz Pharmaceuticals price target raised to $299 from $277 at RBC Capital
Premium
The Fly
Jazz Pharmaceuticals price target raised to $299 from $277 at RBC Capital
26d ago
Jazz Pharmaceuticals price target raised to $310 from $292 at Needham
PremiumThe FlyJazz Pharmaceuticals price target raised to $310 from $292 at Needham
28d ago
Jazz Pharmaceuticals price target raised to $300 from $287 at Deutsche Bank
Premium
The Fly
Jazz Pharmaceuticals price target raised to $300 from $287 at Deutsche Bank
28d ago
Jazz wins FDA nod for Ziihera gastric cancer use
Premium
Company Announcements
Jazz wins FDA nod for Ziihera gastric cancer use
29d ago
Jazz Pharmaceuticals Buy Rating Reaffirmed as Actio Acquisition Bolsters Rare Epilepsy Pipeline; $300 Price Target Maintained
PremiumRatingsJazz Pharmaceuticals Buy Rating Reaffirmed as Actio Acquisition Bolsters Rare Epilepsy Pipeline; $300 Price Target Maintained
1M ago
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger
Premium
Company Announcements
Jazz Pharmaceuticals to Acquire Actio Biosciences in Merger
1M ago
Jazz Pharmaceuticals: Buy Rating Reiterated as Actio Bioscience Acquisition and ABS-1230 Growth Potential Support Unchanged $307 Price Target
Premium
Ratings
Jazz Pharmaceuticals: Buy Rating Reiterated as Actio Bioscience Acquisition and ABS-1230 Growth Potential Support Unchanged $307 Price Target
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100